| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1924 |
0-24 |
Sentence |
denotes |
Declarations of interest |
| T1925 |
25-50 |
Sentence |
denotes |
Thomas Struyf: none known |
| T1926 |
51-79 |
Sentence |
denotes |
Jonathan J Deeks: none known |
| T1927 |
80-109 |
Sentence |
denotes |
Jacqueline Dinnes: none known |
| T1928 |
110-138 |
Sentence |
denotes |
Yemisi Takwoingi: none known |
| T1929 |
139-166 |
Sentence |
denotes |
Clare Davenport: none known |
| T1930 |
167-198 |
Sentence |
denotes |
Mariska MG Leeflang: none known |
| T1931 |
199-312 |
Sentence |
denotes |
René Spijker: the Dutch Cochrane Centre (DCC) has received grants for performing commissioned systematic reviews. |
| T1932 |
313-392 |
Sentence |
denotes |
In no situation, the commissioner had any influence on the results of the work. |
| T1933 |
393-416 |
Sentence |
denotes |
Lotty Hooft: none known |
| T1934 |
417-453 |
Sentence |
denotes |
Devy Emperador: is employed by FIND. |
| T1935 |
454-633 |
Sentence |
denotes |
FIND has several clinical research projects to evaluate multiple new diagnostic tests against published Target Product Profiles that have been defined through consensus processes. |
| T1936 |
634-855 |
Sentence |
denotes |
These studies are for diagnostic products developed by private sector companies who provide access to know‐how, equipment/reagents, and contribute through unrestricted donations as per FIND policy and external SAC review. |
| T1937 |
856-935 |
Sentence |
denotes |
Sabine Dittrich: is employed by FIND with funding from DFID and Australian Aid. |
| T1938 |
936-1040 |
Sentence |
denotes |
FIND is a global non‐for profit product development partnership and WHO Diagnostic Collaboration Centre. |
| T1939 |
1041-1435 |
Sentence |
denotes |
It is FIND’s role to accelerate access to high quality diagnostic tools for low resource settings and this is achieved by supporting both R&D and access activities for a wide range of diseases, including COVID‐19. .FIND has several clinical research projects to evaluate multiple new diagnostic tests against published Target Product Profiles that have been defined through consensus processes. |
| T1940 |
1436-1657 |
Sentence |
denotes |
These studies are for diagnostic products developed by private sector companies who provide access to know‐how, equipment/reagents, and contribute through unrestricted donations as per FIND policy and external SAC review. |
| T1941 |
1658-1681 |
Sentence |
denotes |
Julie Domen: none known |
| T1942 |
1682-1709 |
Sentence |
denotes |
Sebastiaan Horn: none known |
| T1943 |
1710-1739 |
Sentence |
denotes |
Ann Van den Bruel: none known |
